Table 3.
Level of compliance of individual API content and failing rates of anti-malarial samples
| Anti-malarial sample | Number of samples | Level of compliance of API content | Remarks | Number and rate of failing samples | ||
|---|---|---|---|---|---|---|
| API | compliant | noncompliant | ||||
| ATS/SP | 4 | ATS | 4 | 0 | All the 4 samples were noncompliant | 4 (100%) |
| S | 0 | 4 | ||||
| P | 2 | 2 | ||||
| ATS/SmP | 5 | ATS | 2 | 3 | Compliant APIs did not occur in the same samples therefore all the samples were noncompliant | 5 (100%) |
| Sm | 1 | 4 | ||||
| P | 2 | 3 | ||||
| ATM/LUM | 41 | ATM | 14 | 27 | Only 2 samples had both APIs being compliant in the same sample. | 39 (95.1%) |
| LUM | 11 | 30 | ||||
| DHA/Pp | 14 | DHA | 4 | 10 | Pp API could not be assayed. Based on DHA alone, 4 out of 14 samples were compliant | 10 (71.4%) |
| Pp | - | - | ||||
| DHA/SP | 12 | DHA | 0 | 12 | All the samples were noncompliant even though P was 100% compliant | 12 (100%) |
| S | 1 | 11 | ||||
| P | 12 | 0 | ||||
| SP | 23 | S | 3 | 20 | Only 2 samples had both APIs being compliant in the same sample | 21 (91.3%) |
| P | 12 | 11 | ||||
| QN | 13 | QN | 5 | 8 | 5 out 13 samples were compliant | 8 (61.5%) |
| Total | 112 | 73 | 145 | 99 (88.4%) | ||